PB2010: FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES: A GLOBAL, RETROSPECTIVE OBSERVATIONAL COHORT STUDY

• Amer M. Zeidan,
• Aleksandra Butrym,
• Aylin Yucel,
• Gaurav Deshpande,
• Min Che,
• Tao Gu,
• Hong Xiao,
• Dimana Miteva,
• Jose Alberto Nadal,
• T. Kim Le,
• Argiris Symeonidis

Affiliations

Amer M. Zeidan

1 Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT, United States

Aleksandra Butrym

2 Department of Cancer Prevention and Therapy, Wroclaw Medical University, Wroclaw, Poland

Aylin Yucel

3 Bristol Myers Squibb, Princeton, NJ, United States

Gaurav Deshpande

3 Bristol Myers Squibb, Princeton, NJ, United States

Min Che

3 Bristol Myers Squibb, Princeton, NJ, United States

Tao Gu

3 Bristol Myers Squibb, Princeton, NJ, United States

Hong Xiao

3 Bristol Myers Squibb, Princeton, NJ, United States

Dimana Miteva

3 Bristol Myers Squibb, Princeton, NJ, United States

Jose Alberto Nadal

3 Bristol Myers Squibb, Princeton, NJ, United States

T. Kim Le

3 Bristol Myers Squibb, Princeton, NJ, United States

Argiris Symeonidis

4 University of Patras Medical School, Hematology Division, Patras, Greece